mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.9 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.9 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.0048 |
0.9 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |